31st Jul 2008 07:00
RNS Number : 2607A
Victrex PLC
31 July 2008
31 July 2008
Victrex plc
Interim Management Statement
This statement comprises Victrex's Interim Management Statement covering the period from 1 April 2008 to date.
Trading since our May half yearly report has remained in line with expectations. The encouraging start to the second half has continued, with average monthly sales volume for the four months to the end of July above that seen in the first half.
There have been no significant changes in the financial position of the Company since 31 March 2008.
The Company's annual trading update for the year to 30 September 2008 will be issued on Tuesday 7 October 2008.
- Ends -
For further information please contact:
|
Victrex plc
Michael Peacock, Finance Director
|
0207 357 9477 (31 July 2008)
01253 897700 (thereafter)
|
|
Hogarth Partnership Limited
Barnaby Fry / Nick Denton
|
0207 357 9477
|
Victrex plc is an innovative, world leader in high performance materials through the manufacture of VICTREX® PEEKä polymer, a high performance, easy to process thermoplastic.
VICTREXPEEK has a unique combination of chemical, wear, electrical, hydrolysis and temperature resistance, as well as excellent dimensional, mechanical and chemical stability combined with inherent purity and low flammability.
End users specify VICTREX PEEK to reduce systems costs, improve part performance, exploit greater design freedom and create a differentiated application. VICTREX PEEK is used across a broad range of applications in diverse markets including transport, industrial, electronics and medical. Invibio®, Victrex’s biomaterial business, provides specialised solutions for medical device manufacturers.
The Group’s headquarters are in the UK where its manufacturing facilities are based. This is complemented by a global network of sales, distribution and technical centres that serve more than 30 countries worldwide.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IMSEAKXEDFDPEFE
Related Shares:
Victrex
